Cauchy hyper-graph Laplacian nonnegative matrix factorization for single-cell RNA-sequencing data analysis DOI Creative Commons

Gao-Fei Wang,

Longying Shen

BMC Bioinformatics, Год журнала: 2024, Номер 25(1)

Опубликована: Апрель 29, 2024

Abstract Many important biological facts have been found as single-cell RNA sequencing (scRNA-seq) technology has advanced. With the use of this technology, it is now possible to investigate connections among individual cells, genes, and illnesses. For analysis data, clustering frequently used. Nevertheless, data usually contain a large amount noise traditional methods are sensitive noise. However, acquiring higher-order spatial information from alone insufficient. As result, getting trustworthy findings challenging. We propose Cauchy hyper-graph Laplacian non-negative matrix factorization (CHLNMF) unique approach address these issues. In CHLNMF, we replace measurement based on Euclidean distance in conventional (NMF), which can lessen influence noise, with loss function (CLF). The model also incorporates constraint, takes into account high-order link samples. CHLNMF model's best solution then discovered using half-quadratic optimization approach. Finally, seven scRNA-seq datasets, contrast technique other nine top methods. validity our was established by experimental outcomes.

Язык: Английский

Metal-Based Nanoparticles for Cardiovascular Diseases DOI Open Access
Alexandru Scafa‐Udriște,

Alexandra Cristina Burdușel,

Adelina-Gabriela Niculescu

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(2), С. 1001 - 1001

Опубликована: Янв. 13, 2024

Globally, cardiovascular diseases (CVDs) are the leading cause of death and disability. While there many therapeutic alternatives available for management CVDs, majority classic strategies were found to be ineffective at stopping or significantly/additionally slowing progression these diseases, they had unfavorable side effects. Numerous metal-based nanoparticles (NPs) have been created overcome limitations, demonstrating encouraging possibilities in treatment CVDs due advancements nanotechnology. Metallic nanomaterials, including gold, silver, iron, come various shapes, sizes, geometries. NPs generally smaller more specialized physical, chemical, biological properties. Metal-based may forms, such as nanoshells, nanorods, nanospheres, studied most. Massive potential applications metal nanomaterial structures include supporting molecular imaging, serving drug delivery systems, enhancing radiation-based anticancer therapy, supplying photothermal transforming effects thermal being compounds with bactericidal, fungicidal, antiviral qualities that helpful diseases. In this context, present paper aims review relevant oxide creating an up-to-date framework aids researchers developing efficient strategies.

Язык: Английский

Процитировано

19

Informatics strategies for early detection and risk mitigation in pancreatic cancer patients DOI Creative Commons
Di Jin, Najeeb Ullah Khan, Wei Gu

и другие.

Neoplasia, Год журнала: 2025, Номер 60, С. 101129 - 101129

Опубликована: Янв. 21, 2025

Язык: Английский

Процитировано

4

Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics DOI Creative Commons
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 208, С. 115302 - 115302

Опубликована: Апрель 3, 2024

Cardiovascular diseases (CVDs) stand as the leading cause of death worldwide, posing a significant global health challenge. Consequently, development innovative therapeutic strategies to enhance CVDs treatment is imperative. RNA-based therapies, encompassing non-coding RNAs, mRNA, aptamers, and CRISPR/Cas9 technology, have emerged promising tools for addressing CVDs. However, inherent challenges associated with RNA, such poor cellular uptake, susceptibility RNase degradation, capture by reticuloendothelial system, underscore necessity combining these therapies effective drug delivery systems. Various non-viral systems, including extracellular vesicles, lipid-based carriers, polymeric inorganic nanoparticles, well hydrogels, shown promise in enhancing efficacy RNA therapeutics. In this review, we offer an overview most relevant explored emphasize pivotal role systems augmenting their effectiveness. Additionally, discuss current status that hinder clinical translation.

Язык: Английский

Процитировано

13

Nano revolution in cardiovascular health: Nanoparticles (NPs) as tiny titans for diagnosis and therapeutics DOI
Junaid Abid, Fatma Mohamed Ameen Khalil, Sumbul Saeed

и другие.

Current Problems in Cardiology, Год журнала: 2024, Номер 49(5), С. 102466 - 102466

Опубликована: Фев. 16, 2024

Язык: Английский

Процитировано

4

Cytotoxicity and genotoxicity induced by metal-based nanoparticles in humans and animals DOI Creative Commons

Lala Rukh,

Saif Ullah,

Muhammad Ameer Qarib Naqvi

и другие.

Deleted Journal, Год журнала: 2024, Номер unknown, С. 01 - 10

Опубликована: Июль 19, 2024

The growing interest in nanoparticles modern research is due to their potential uses different fields of study. Throughout human history, individuals have been exposed environmental nanosized particles, and over the past century, these exposures significantly risen. Through injection, ingestion, inhalation, can change material's physicochemical characteristics improve its ability absorb interact with biological tissues. Nanoparticles penetrate cell membrane reach up mitochondria nucleus, causing gene mutation inhibiting mitochondrial process involved metabolism. toxicity associated size, shape, charge, surface area, chemical composition, other linked factors. vivo behavior still a major question that needs be resolved. tests are performed against new during developmental eliminate or ameliorate identified toxic characteristics.

Язык: Английский

Процитировано

3

Innovative engineering of superoxide dismutase for enhanced cardioprotective biocatalysis in myocardial ischemia-reperfusion injury DOI
Bo Zhao,

Jianjun Peng,

C. Chen

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 286, С. 137656 - 137656

Опубликована: Ноя. 28, 2024

Язык: Английский

Процитировано

3

Advances in developing novel therapeutics, strategies, approaches, and use of emerging techniques DOI
Prasann Kumar

Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 291 - 318

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Tailoring the Surface of Multifunctional Magnetic Nanoparticles: Modification and Functionalization Strategies DOI
Valentine Chikaodili Anadebe, Abhinay Thakur,

Chukwunonso Chukwuzuluoke Okoye

и другие.

Royal Society of Chemistry eBooks, Год журнала: 2025, Номер unknown, С. 30 - 82

Опубликована: Май 7, 2025

Magnetic nanoparticles (MNPs) can have their surfaces modified to customize functions and properties for a range of uses. In order achieve multifunctionality, this chapter thoroughly analyzes the methods tactics used alter functionalize MNPs. Surface modification is examined in context fundamental elements MNPs, such as synthesis techniques magnetic behavior. The benefits drawbacks several surface methods, including coating, ligand exchange, silanization, polymer grafting, are explained. Furthermore, functionalization strategies environmental biological applications, emphasizing attachment medicinal agents, adsorbents, imaging probes, targeting ligands. For scholars practitioners who intrigued by design optimization MNPs various provides thorough reference.

Язык: Английский

Процитировано

0

Recent developments in nanoparticle-based treatment for atrial fibrillation and other human cardiac arrhythmias DOI Open Access

Jared Gabriel L. Dela Rosa,

Nathan Ross B. Bantayan, Ourlad Alzeus G. Tantengco

и другие.

The Journal of Cardiovascular Aging, Год журнала: 2025, Номер 5(2)

Опубликована: Май 8, 2025

This review aims to summarize the current landscape of cardiac arrhythmia therapeutics and highlight recent advances in nanoparticle-based strategies for treatment various human arrhythmias. A comprehensive literature was conducted curate synthesize preclinical developments nanoparticle-mediated therapies targeting Cardiac arrhythmias represent one most prevalent challenging forms cardiovascular disease worldwide. Conventional treatments, including antiarrhythmic drugs, are often limited by suboptimal efficacy, high recurrence rates, significant off-target toxicities. While catheter-based ablation techniques have emerged as alternative interventions, their long-term success remains inconsistent, highlighted outcomes from large trials such CABANA trial. In response these limitations, interventions a promising class therapeutics. These offer potential advantages, site-specific drug delivery, reduced systemic toxicity, novel approaches both pharmacologic ablative therapy. presents an overview emerging atrial fibrillation other It also discusses proof-of-concept studies, evaluates benefits limitations nanoparticle formulations, outlines key challenges future directions translating technologies into clinical practice.

Язык: Английский

Процитировано

0

Machine learning reshapes the paradigm of nanomedicine research DOI Creative Commons

Ziye Wei,

Shijie Zhuo,

Yixin Zhang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2025, Номер unknown

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0